Show simple item record

dc.contributor.authorAung, N
dc.contributor.authorDoimo, S
dc.contributor.authorRicci, F
dc.contributor.authorSanghvi, MM
dc.contributor.authorPedrosa, C
dc.contributor.authorWoodbridge, SP
dc.contributor.authorAl-Balah, A
dc.contributor.authorZemrak, F
dc.contributor.authorKhanji, MY
dc.contributor.authorMunroe, PB
dc.contributor.authorNaci, H
dc.contributor.authorPetersen, SE
dc.date.accessioned2020-04-22T12:34:20Z
dc.date.available2019-11-27
dc.date.available2020-04-22T12:34:20Z
dc.date.issued2020-01-21
dc.identifier.citationAung, N., et al. (2020). "Prognostic Significance of Left Ventricular Noncompaction." Circulation: Cardiovascular Imaging 13(1): e009712.en_US
dc.identifier.issn1941-9651
dc.identifier.urihttps://qmro.qmul.ac.uk/xmlui/handle/123456789/63688
dc.description.abstractBACKGROUND: Although left ventricular noncompaction (LVNC) has been associated with an increased risk of adverse cardiovascular events, the accurate incidence of cardiovascular morbidity and mortality is unknown. We, therefore, aimed to assess the incidence rate of LVNC-related cardiovascular events. METHODS: We systematically searched observational studies reporting the adverse outcomes related to LVNC. The primary end point was cardiovascular mortality. RESULTS: We identified 28 eligible studies enrolling 2501 LVNC patients (mean age, 46 years; male/female ratio, 1.7). After a median follow-up of 2.9 years, the pooled event rate for cardiovascular mortality was 1.92 (95% CI, 1.54-2.30) per 100 person-years. LVNC patients had a similar risk of cardiovascular mortality compared with a dilated cardiomyopathy control group (odds ratio, 1.10 [95% CI, 0.18-6.67]). The incidence rates of all-cause mortality, stroke and systemic emboli, heart failure admission, cardiac transplantation, ventricular arrhythmias, and cardiac device implantation were 2.16, 1.54, 3.53, 1.24, 2.17, and 2.66, respectively, per 100 person-years. Meta-regression and subgroup analyses revealed that left ventricular ejection fraction, not the extent of left ventricular trabeculation, had an important influence on the variability of incidence rates. The risks of thromboembolism and ventricular arrhythmias in LVNC patients were similar to dilated cardiomyopathy patients. However, LVNC patients had a higher incidence of heart failure hospitalization than dilated cardiomyopathy patients. CONCLUSIONS: Patients with LVNC carry a similar cardiovascular risk when compared with dilated cardiomyopathy patients. Left ventricular ejection fraction-a conventional indicator of heart failure severity, not the extent of trabeculation-appears to be an important determinant of adverse outcomes in LVNC patients. Registration: https://www.crd.york.ac.uk/PROSPERO/ Unique identifier: CRD42018096313.en_US
dc.description.sponsorshipDr Aung is supported by a Wellcome Trust Research Training Fellowship (203553/Z/Z). Drs Petersen and Aung acknowledge the support through the Barts Biomedical Research Centre, which is funded by the National Institute for Health Research.en_US
dc.format.extente009712 - ?
dc.languageeng
dc.language.isoenen_US
dc.publisherAmerican Heart Association, Inc., by Wolters Kluwer Health, Incen_US
dc.relation.ispartofCirc Cardiovasc Imaging
dc.rightsCC-BY
dc.rightsAttribution 3.0 United States*
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/us/*
dc.subjectcardiac imaging techniquesen_US
dc.subjectcardiomyopathiesen_US
dc.subjectmeta-analysisen_US
dc.subjectprognosisen_US
dc.titlePrognostic Significance of Left Ventricular Noncompaction: Systematic Review and Meta-Analysis of Observational Studies.en_US
dc.typeArticleen_US
dc.rights.holder2020 The Authors
dc.identifier.doi10.1161/CIRCIMAGING.119.009712
pubs.author-urlhttps://www.ncbi.nlm.nih.gov/pubmed/31959004en_US
pubs.issue1en_US
pubs.notesNot knownen_US
pubs.publication-statusPublisheden_US
pubs.volume13en_US
dcterms.dateAccepted2019-11-27
rioxxterms.funderDefault funderen_US
rioxxterms.identifier.projectDefault projecten_US
qmul.funderClinical Research Training Fellowship::Wellcome Trusten_US
qmul.funderClinical Research Training Fellowship::Wellcome Trusten_US


Files in this item

Thumbnail
Thumbnail

This item appears in the following Collection(s)

Show simple item record

CC-BY
Except where otherwise noted, this item's license is described as CC-BY